SUMMARY Syncopal attacks in patients with bifascicular block may be due to both ventricular tachyarrhythmias and intermittent atrioventricular block in addition to non-cardiac causes and lead to antiarrhythmic treatment with drugs or pacemaker or both. The acute electrophysiological effect of intravenous disopyramide 2 mg/kg body weight given over five minutes on the His-Purkinje system was assessed in 27 patients with chronic bifascicular block undergoing evaluation for permanent pacemaker treatment. The predictive value of this pharmacological stress test as regards the development of atrioventricular block during follow up was analysed. The HV interval increased (mean 43%) and the QRS duration was prolonged (mean 24%). Intrahisian or infrahisian second or third degree atrioventricular block occurred in 14 patients after disopyramide administration, requiring temporary pacing in four of them. Before the electrophysiological study 15 of the 27 patients had had at least two syncopal attacks of suspected cardiac origin but no evidence of second or third degree atrioventricular block. Second or third degree atrioventricular block was subsequently recorded in five of these 15 patients during a mean of two years follow up. The sensitivity, specificity, and predictive value of second or third degree atrioventricular block produced by disopyramide administration including subsequent atrial pacing-a positive disopyramide test-as regards later development of atrioventricular block were 80%/o, 900/o, and 8O0/o respectively. 
Disopyramide induced second and third degree atrioventricular block Bergfeldt, Rosenqvist, Vallin, Edhag heart rate (pure pharmacological provocation). Secondly, the test was positive if second or third degree atrioventricular block, intraHis or infraHis, appeared during atrial pacing subsequent to the disopyramide administration. 12 Thirdly, the test was positive if second or third degree atrioventricular block, intraHis or infraHis, appeared after abruptly terminated ventricular pacing subsequent to disopyramide administration. The reason for using right ventricular pacing as a stress test was the observation during the electrophysiological study of one of the first investigated patients (case 13). After disopyramide injection he developed complete infraHis heart block immediately after a spontaneous ventricular extrasystole and subsequently, and in a reproducible manner, after short periods of ventricular pacing. Finally, we also analysed the value of the HV prolongation induced by disopyramide administration. According to previous results the expected prolongation would be on average 20% after the same dosage.6 We arbitrarily chose a 50%h prolongation as the lower limit for a potential predictor.
FOLLOW UP
During follow up the patients were seen three to four times a year, their history assessed, and a standard electrocardiogram recorded. When necessary the pulse generator was set low to elucidate the underlying spontaneous heart rhythm. , did not change in one (case 6), and could not be measured in one (case 3) because of complete heart block. In 10 patients the HV prolongation produced by disopyramide was 50% or more ( Table 1 ). The QRS duration was prolonged by a mean of 24% (p < 0.001).
SECOND AND THIRD DEGREE ATRIOVENTRICULAR BLOCK AFTER DISOPYRAMIDE (TABLE 1) The disopyramide administration induced intrahisian or infrahisian second (cases 1
Group I -Of the nine patients, six (67%) developed atrioventricular block after disopyramide injection, three from pure pharmacological provocation, two from subsequent atrial pacing, and one after ventricular pacing. Of the other three patients, two had had a myocardial infarction. One patient (case 6) had an anterolateral wall infarction two weeks before the investigation and complete heart block after verapamil treatment for rapid atrial fibrillation. The other patient (case 8) had an infarction of the inferior wall, with involvement of the anterior and lateral parts of the left ventricular wall one month before the study.
Group 2-Disopyramide induced atrioventricular block by pure pharmacological provocation in three patients, by atrial pacing in two (plus one of the previous three), and Second or third degree atrioventricular block was recorded in two of the nine patients in group 1 during follow up. In five (four of 11 with right bundle branch block with left anterior fascicular block and one of two with left bundle branch block) of the 15 patients in group 2 second or third degree atrioventricular block occurred 3-38 months after the electrophysiological study. In none of the three patients in group 3 was second or third degree atrioventricular block recorded during follow up.
PREDICTION OF ATRIOVENTRICULAR BLOCK PROGRESSION (TABLE 2)
The results of possible prognostic variables and tests-that is, the presence of an HV prolongation to 270 ms in the basal state and a positive disopyramide test-were related to the occurrence of second or third degree atrioventricular block.
An HV interval of 270 ms in the basal state was seen in five patients, two in group 1 and three in group 2. This finding was a specific (90-92%) but insensitive (29-40%) indicator of previous or subsequent occurrence of atrioventricular block.
The results of the disopyramide test are given separately for the three groups. In this analysis the three different groups served different purposes. Group 1 gave an indication of the sensitivity and group 3 of the specificity of the disopyramide test. Group 2 was then used to define the prognostic or predictive values.
In group 1 a comparison was made with the episodes of atrioventricular block that were recorded before the electrophysiological study. As by definition all these patients had had transient second or third degree atrioventricular block this comparison gave an indication of the sensitivity of the disopyramide provocation. Seven out of nine patients had a positive test, which gave a sensitivity of 78%.
Group 3 on the other hand indicated the specificity of the disopyramide provocation as the patients had neither a history nor symptoms of second or third degree atrioventricular block. One of these three patients had an HV prolongation of more than 50% after disopyramide; otherwise the disopyramide test was negative. Atrioventricular block was not recorded in these patients during 12, 50, and 53 months of follow up.
Group 2 comprised patients in whom a test like the disopyramide provocation would probably have its clinical applicability in the future-that is, as a prognostic test. Initially, the disopyramide test was tentatively considered to be positive in four circumstances. Table 2 shows that the result of ventricular pacing and an HV prolongation of ,50% after disopyramide injection both had poor sensitivity and specificity for the occurrence of second or third degree atrioventricular block. If, however, a positive disopyramide test was defined as second or third degree atrioventricular block occurring with pure pharmacological provocation and after subsequent atrial pacing the prognostic value of the test is greatly improvednamely sensitivity 80%o, specificity 900/o, and predictive value of a positive test 80%. The best predictive value was, however, obtained if an HV prolongation to >70 ms in the basal state and a positive disopyramide test were combined. In our group of patients this latter combination gave a sensitivity of 100%, a specificity of 900/o, and a predictive value of a positive test of 83%.
Discussion SHORT TERM EFFECT OF DISOPYRAMIDE
Contrary to previous experience6 we thus found that the intravenous administration of disopyramide 2 mg/kg body weight can induce second and third degree atrioventricular block in patients with bifascicular block. In the study by Desai et al patients with a recent acute myocardial infarction and patients with evidence of second or third degree atrioventricular block were excluded.6 Sixteen of their 22 patients had bifascicular block and-six right bundle branch block. The disopyramide dose was the same, but the infusion rate was seven minutes in their study and five minutes in ours, the difference probably being of little importance. A point of utmost importance is the presence of cardiogenic syncopal attacks, which could either be attributed to ventricular tachyarrhythmias or intermittent second or third degree atrioventricular block. In the report by Desai et al the presence or absence of syncopal attacks was not stated.6 Assuming that none of their patients had had syncopal attacks, their group of patients would be comparable to our group 3, and then no discrepancy in results would exist. It is, however, the patients with syncopal attacks who require most diagnostic and therapeutic consideration.
In two recent reports of patients with bifascicular block and syncope of uncertain origin the ability of subsequently performed programmed stimulation to induce ventricular tachycardias has been taken as evidence for their causative role.'4'5 Our study protocol did not include programmed stimulation for the routine provocation of ventricular tachyarrhythmias, but it was performed in one patient (case 19). In this patient, non-sustained ventricular tachycardias could be induced in the right ventricular outflow tract before, but not after, disopyramide administration. As the disopyramide was well tolerated and the electrophysiological study was otherwise normal, this patient was subsequently prescribed oral disopyramide. He has been free of symptoms during follow up. As regards the other patients, the absence of recurrent syncopal attacks in most cases indicated the absence also of ventricular tachycardias, although it cannot be excluded that this arrhythmia was the cause of the previous syncopal attacks and that spontaneous remission had occurred.
ATRIOVENTRICULAR BLOCK PROGRESSION IN PATIENTS WITH BIFASCICULAR BLOCK
The prevalence of bifascicular block is 1-15% in the adult population,2 [16] [17] [18] but the yearly incidence of atrioventricular block progression is only 1-4%. [1] [2] [3] No clinical or standard electrocardiographic features have been found to predict progress to second or third degree atrioventricular block. '9 Three principally different electrophysiological factors of prognostic value have previously been identified: (a) an HV prolongation in the basal state,'-3 (b) second or third degree atrioventricular Disopyramide induced second and third degree atrioventricular block -block in the His-Purkinje system during atrial pacing,'2 and (c) pharmacological provocation of atrioventricular block with procainamide20 and ajmaline.2'
The reason for choosing disopyramide in this study was that it has both class I antiarrhythmic properties, like procainamide and ajmaline, and also class III properties and anticholinergic effects.4 Our hypothesis was that latent His-Purkinje disturbances could be provoked (a) by the class I and III antiarrhythmic effects and (b) by atrially paced impulses reaching the distal conduction system at higher rates as vagally depressed atrioventricular nodal conduction would be counteracted by the anticholinergic effect. Disopyramide would thus provide an opportunity to combine the principles (b) and (c) in the previous paragraph.
The occurrence of second and third degree intrahisian or infrahisian atrioventricular block during disopyramide administration may be a provocation of intermittent atrioventricular block, an unmasking of a latent predisposition for atrioventricular block, or an adverse reaction to the drug that is unrelated to prognosis. The critical factor for evaluating the prognostic importance of such a reaction is of course the outcome during follow up. The patients were followed with repeated standard electrocardiographic recordings. This method has, however, obvious limitations in evaluating prognostic tests for the development of atrioventricular block. Jensen et al found that more than 50% of patients with third degree atrioventricular block and syncopal attacks had intermittent atrioventricular block and about 75% of the patients in the group with intermittent atrioventricular block had bifascicular block during sinus rhythm.22 It is therefore possible that we were not able to detect intermittent atrioventricular block in some patients. But even with this reservation, we found the disopyramide test to be of potential value in predicting atrioventricular block progression ( number of patients is, however, small, and.the interval between the infarction and the electrophysiological study differs. Two patients (cases 2 and 7) with a false positive disopyramide test as regards later atrioventricular block development were studied three weeks and one month after the infarction, which may be too early.
ADVERSE EFFECTS
An adverse effect of disopyramide administration was seen in one patient. He had before the study had a massive anterior myocardial infarction and was mobilised but not haemodynamically entirely stabilised.
This patient was one of the four who required temporary pacing. The pronounced but transient fall in blood pressure was probably due to a combination of inadequate heart rate and impaired ventricular performance which was further depressed by the negative inotropic effect of disopyramide.25 CONCLUSION The acute intravenous administration of disopyramide to patients with bifascicular block may induce second and third degree atrioventricular block both in patients with previously documented transient second or third degree atrioventricular block and in patients with a history of syncope of suspected cardiac origin. Furthermore, this procedure can be used as a stress test of the His-Purkinje conduction system in the latter group of patients and seems to have a potential value in predicting subsequent development of second or third degree AV block. 
